Picard Medical, Inc. (PMI)
ASE · Medical Devices
Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires
Company overview
Picard Medical, Inc., together with its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products. The company offers SynCardia TAH, an artificial heart for patients that is designed to function as a failed human heart in patients suffering from advanced heart failure. The company operates in the United States, Europe, and internationally. The company was incorporated in 2021 and is headquartered in Tucson, Arizona. Picard Medical, Inc. operates as a subsidiary of Hunniwell Picard I, Llc.
Peers in Medical Devices
All in industry →Abbott Laboratories
Stryker Corporation
Medtronic plc
Boston Scientific Corporation
Edwards Lifesciences Corporation
GE HealthCare Technologies Inc.
Koninklijke Philips N.V.
DexCom, Inc.
STERIS plc
Zimmer Biomet Holdings, Inc.
Recent press releases
April 2026
Picard Medical Reports 79.9% Revenue Growth in Q1 2026
# 🧾 What This Document Is This is a **Form 8-K filing**, which a company uses to announce major news to investors. Attached to it is a press release (Exhibit 99.1) giving the details. In simple terms, Picard Medical is sharing its **preliminary revenue results** for the first three months of 2026 b
SEC filings
All filings →Insider trades
All insider trades →Picard Medical, Inc. has no reported insider trades in the last 90 days.